EL7.AI
BondsMedium•10 November 2026•
4 min read

Pyxus Offers to Exchange 8.50% Notes Due 2027 for Shares and New Debt

Key Facts

1The exchange offer covers outstanding notes with principal of $148,338,952.
2For early tenders, consideration is $344.37 in shares and $675.90 in principal amount of new notes for every $1,000 principal amount of notes.
3For later tenders, consideration is $327.15 in shares and $642.11 in principal amount of new notes for every $1,000 principal amount of notes.
4Completion of the transactions requires participation and consents from holders of at least 99% of the principal amount of each debt class, with the note threshold potentially reduced to 97% in the specified circumstance.

Pyxus International and its subsidiary Pyxus Holdings said on November 10 they had launched a private offer to exchange all of the company’s outstanding 8.50% notes due 2027 and were seeking holders’ consent to amendments to the debt documents, according to a company filing with the U.S. Securities and Exchange Commission. The principal amount of notes covered is $148,338,952. Consideration varies by tender timing and combines Pyxus shares with new secured floating-rate notes. The offer is part of exchange and capital-restructuring transactions supported by agreements with creditors. The transaction goes beyond replacing debt instruments, also including changes to collateral and certain existing contractual protections.

Holders who tender their notes before the early deadline will receive $344.37 in Pyxus shares, calculated at $3.25 per share, plus new notes with aggregate principal of $675.90, for every $1,000 principal amount of notes tendered. Holders who tender after the early deadline and before the offer expires will receive less: $327.15 in shares and new notes with principal of $642.11 for every $1,000 principal amount of notes. An eligible holder whose notes are accepted by the company will receive accrued and unpaid interest through the day before the settlement date. The terms show a direct difference between early and later tenders in the value of shares and principal amount of new notes due to holders. The filing describes the two consideration amounts as part of the offer mechanics, not as a uniform price for all participants.

Pyxus set 5:00 p.m. New York time on November 24, 2026, as the early tender deadline. The offer and consent solicitation will expire at 5:00 p.m. New York time on December 10, 2026. The company expects to settle the exchange on or shortly after December 15, 2026. The timetable allows holders to distinguish between the deadline for receiving early consideration and the transaction’s final expiration. Completion of the exchange remains subject to the participation and consent conditions set out in the filing.

Along with tendering their notes, holders must consent to broad amendments, including the waiver of most restrictive covenants and certain affirmative covenants. The amendments also include eliminating the right to repurchase notes upon a change of control and in certain default situations, and subordinating the existing notes and their collateral to higher-priority debt. The offer also seeks the release of existing collateral securing the current notes. Holders cannot submit consent without tendering their notes, nor tender the notes without consenting to the amendments. The offer thus links the debt exchange to changes in contractual protections and the ranking of claims on assets.

The restructuring is based on a support agreement dated November 5, under which supporting creditors held approximately 56.0% of the outstanding notes, 74.9% of Pyxus loans and 67.9% of Intabex loans. The broader plan includes a private share offering to eligible investors of up to $85 million, at a subscription price of $2.50 per share. $42.5 million of the offering has been reserved for supporting parties. These components link the note exchange to a broader capital reorganization involving loans and a new share issuance. Completion of the exchange transactions and share offering is subject to the consents and participation of holders of at least 99% of the principal amount of each debt class, with the note threshold potentially reduced to 97% in the circumstance specified in the filing; the two transactions must also be completed together or at approximately the same time.

The plan follows results for the second quarter of fiscal 2027, when operating revenue fell to $534.4 million in the quarter ended September 30, 2026, from $570.2 million in the year-earlier period. Tobacco leaf sales volumes declined 15.8%, with shipments from Africa and South America deferred because of shipping constraints and slower purchasing and processing. Net debt was $1,250.5 million at quarter-end, down $13.6 million from a year earlier, and the company had no outstanding borrowings under its $150.0 million revolving asset-based facility. The company maintained its fiscal 2027 sales outlook at $2.3 billion to $2.5 billion, while narrowing its adjusted EBITDA forecast to $215–235 million from a previous range of $210 million to $240 million. PYYX shares closed at $2.4 on November 6, 2026, before the exchange offer was announced.

Open on chart